10-Q/A

FORM 10-Q/A

Company: Protalix BioTherapeutics, Inc.
Filed: June 1, 2020
Period of Report: March 31, 2020
Accession Number: 0001104659-20-068485

View Document ↗ View on SEC.gov ↗